A detailed history of Pictet Asset Management Sa transactions in Arvinas, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 403,034 shares of ARVN stock, worth $8.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
403,034
Previous 531,080 24.11%
Holding current value
$8.02 Million
Previous $14.5 Million 31.06%
% of portfolio
0.01%
Previous 0.02%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$21.73 - $31.43 $2.78 Million - $4.02 Million
-128,046 Reduced 24.11%
403,034 $10 Million
Q1 2023

May 10, 2023

BUY
$26.15 - $37.26 $1.2 Million - $1.71 Million
45,799 Added 9.44%
531,080 $14.5 Million
Q4 2022

Feb 13, 2023

SELL
$32.47 - $57.24 $445,098 - $784,645
-13,708 Reduced 2.75%
485,281 $16.6 Million
Q3 2022

Nov 14, 2022

SELL
$41.87 - $57.99 $2.08 Million - $2.89 Million
-49,764 Reduced 9.07%
498,989 $22.2 Million
Q2 2022

Aug 09, 2022

SELL
$36.01 - $74.24 $186,819 - $385,157
-5,188 Reduced 0.94%
548,753 $23.1 Million
Q1 2022

May 13, 2022

SELL
$60.27 - $81.57 $818,466 - $1.11 Million
-13,580 Reduced 2.39%
553,941 $37.3 Million
Q4 2021

Feb 10, 2022

BUY
$65.85 - $96.21 $6.87 Million - $10 Million
104,312 Added 22.52%
567,521 $46.6 Million
Q3 2021

Nov 12, 2021

BUY
$73.2 - $107.87 $33.9 Million - $50 Million
463,209 New
463,209 $38.1 Million

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.06B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.